Rolf Kemler (born 13 February 1945), is a German molecular biologist who is currently the Emeritus Director at the Max Planck Institute of Immunobiology and Epigenetics. [1] He has contributed significantly to the study of anchoring junctions, specifically the cadherin family of proteins and was the recipient of the 2020 Canada Gairdner International Award for his work in the field. [2]
The Max Planck Institute of Biochemistry (MPIB) is a research institute of the Max Planck Society located in Martinsried, a suburb of Munich. The institute was founded in 1973 by the merger of three formerly independent institutes: the Max Planck Institute of Biochemistry, the Max Planck Institute of Protein and Leather Research, and the Max Planck Institute of Cell Chemistry.
The Gottfried Wilhelm Leibniz Prize, or Leibniz Prize, is awarded by the German Research Foundation to "exceptional scientists and academics for their outstanding achievements in the field of research". Since 1986, up to ten prizes have been awarded annually to individuals or research groups working at a research institution in Germany or at a German research institution abroad. It is considered the most important research award in Germany.
The Max Planck Institute of Colloids and Interfaces is located in Potsdam-Golm Science Park in Golm, Potsdam, Germany. It was founded in 1990 as a successor of the Institute for Physical Chemistry and for Organic Chemistry, both in Berlin-Adlershof, and for Polymer Chemistry in Teltow. In 1999, it transferred to newly constructed extension facilities in Golm. It is one of 80 institutes in the Max Planck Society (Max-Planck-Gesellschaft).
The Max Planck Institute for Medical Research in Heidelberg, Germany, is a facility of the Max Planck Society for basic medical research. Since its foundation, six Nobel Prize laureates worked at the Institute: Otto Fritz Meyerhof (Physiology), Richard Kuhn (Chemistry), Walther Bothe (Physics), André Michel Lwoff, Rudolf Mößbauer (Physics), Bert Sakmann and Stefan W. Hell (Chemistry).
The Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany is an interdisciplinary research institute that conducts basic research in modern immunobiology, developmental biology and epigenetics. It was founded in 1961 as the Max Planck Institute of Immunobiology and is one of 86 institutions of the Max Planck Society. Originally named the Max Planck Institute of Immunobiology, it was renamed to its current name in 2010 as it widened its research thrusts to the study of epigenetics.
The International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB) is an international PhD program in molecular biology and cellular biology founded in 2006 by the Max Planck Institute of Immunobiology and Epigenetics and the University of Freiburg.
Franz-Ulrich Hartl is a German biochemist and Managing Director of the Max Planck Institute of Biochemistry. He is known for his pioneering work in the field of protein-mediated protein folding and is a recipient of the 2011 Lasker Award along with Arthur L. Horwich.
The Wiley Prize in Biomedical Sciences is intended to recognize breakthrough research in pure or applied life science research that is distinguished by its excellence, originality and impact on our understanding of biological systems and processes. The award may recognize a specific contribution or series of contributions that demonstrate the nominee's significant leadership in the development of research concepts or their clinical application. Particular emphasis will be placed on research that champions novel approaches and challenges accepted thinking in the biomedical sciences.
Dietmar Vestweber is a biochemist and cell biologist. He is the founding director of the Max Planck Institute for Molecular Biomedicine in Münster, Germany.
Emmanuelle Marie Charpentier is a French professor and researcher in microbiology, genetics, and biochemistry. As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin. In 2018, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens. In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing". This was the first science Nobel Prize ever won by two women only.
Thomas Jenuwein is a German scientist working in the fields of epigenetics, chromatin biology, gene regulation and genome function.
Christoph Bock is a German bioinformatician and principal investigator at the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences and a visiting professor at the Medical University of Vienna.
Azim Surani is a Kenyan-British developmental biologist who has been Marshall–Walton Professor at the Wellcome Trust/Cancer Research UK Gurdon Institute at the University of Cambridge since 1992, and Director of Germline and Epigenomics Research since 2013.
Xu Guoliang is a Chinese molecular geneticist. He is a professor at the Shanghai Institute of Biochemistry and Cell Biology and an academician of the Chinese Academy of Sciences.
Davor Solter is a Yugoslavian-born developmental biologist, particularly known for his pioneering work on mammalian genomic imprinting. He is Emeritus Member and Director, Max Planck Institute of Immunobiology and Epigenetics; Visiting International Professor, Siriraj Center for Excellence in Stem Cell Research, Mahidol University, Thailand; and Visiting Professor, University of Zagreb Medical School.
Ibrahim I. Cissé is an Nigerien-American biophysicist. He is currently director of the Max Planck Institute of Immunobiology and Epigenetics. Previously, Cissé was at the California Institute of Technology as Professor of Physics and the Massachusetts Institute of Technology as Professor of Physics and Biology. He has won several awards for his work, including in 2021 the MacArthur Fellowship.
Asifa Akhtar is a Pakistani biologist who has made significant contributions to the field of chromosome regulation. She is Senior Group Leader and Director of the Department of Chromatin Regulation at the Max Planck Institute of Immunobiology and Epigenetics. Akhtar was awarded EMBO membership in 2013. She became the first international and female Vice President of the Max Planck Society's Biology and Medicine Section in July 2020.
Erika L. Pearce is an American immunologist. She is the Bloomberg Distinguished Professor at the Johns Hopkins University after serving as director and a scientific member at Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany. Her work investigates the connection between metabolism and immune cell function with a particular focus on the regulation of T-cells. In 2018, she was awarded the Leibniz Prize for her "outstanding work in metabolism and inflammation research."
Hedda Wardemann is an immunologist and Professor in the Division of B cell immunology at the German Cancer Research Center in Heidelberg, Germany.
Thomas Boehm is a German immunologist. He is the Director of the Max Planck Institute for Immunobiology and Epigenetics in Freiburg im Breisgau. He has won a variety of prizes for his research work.